Two Sigma Investments, LP Brainstorm Cell Therapeutics Inc. Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.2 - $2.08 $5,630 - $58,556	28,152 Added 57.42%	77,179 $15,000
Q2 2023 Aug 14, 2023	BUY	$2.0 - $3.2 $98,054 - $156,886	49,027 New	49,027 $100,000
Q4 2021 Feb 14, 2022	SELL	$2.81 - $4.23 $44,679 - $67,257	-15,900 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $100,925 - $131,460	-32,142 Reduced 66.9%	15,900 $52,000
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $206,058 - $274,516	-68,458 Reduced 58.76%	48,042 $183,000
Q1 2021 May 17, 2021	BUY	$3.46 - $7.88 $94,378 - $214,942	27,277 Added 30.57%	116,500 $446,000
Q4 2020 Feb 16, 2021	BUY	$3.99 - $17.73 $355,999 - $1.58 Million	89,223 New	89,223 $404,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.